Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction
E González-López, M Gallego-Delgado… - European heart …, 2015 - academic.oup.com
Aims Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous clinical
syndrome with multiple underlying causes. Wild-type transthyretin (TTR) amyloidosis …
syndrome with multiple underlying causes. Wild-type transthyretin (TTR) amyloidosis …
Magnetic resonance in transthyretin cardiac amyloidosis
A Martinez-Naharro, TA Treibel, A Abdel-Gadir… - Journal of the American …, 2017 - jacc.org
Background: Cardiac transthyretin amyloidosis (ATTR) is an increasingly recognized cause
of heart failure. Cardiac magnetic resonance (CMR), with late gadolinium enhancement …
of heart failure. Cardiac magnetic resonance (CMR), with late gadolinium enhancement …
Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey)
MS Maurer, M Hanna, M Grogan, A Dispenzieri… - Journal of the American …, 2016 - jacc.org
Background: Transthyretin amyloidosis (ATTR) is a heterogeneous disorder with multiorgan
involvement and a genetic or nongenetic basis. Objectives: The goal of this study was to …
involvement and a genetic or nongenetic basis. Objectives: The goal of this study was to …
Хроническая сердечная недостаточность. Клинические рекомендации 2020
СН Терещенко, АС Галявич, ТМ Ускач… - Российский …, 2020 - cyberleninka.ru
КТИ—кардиоторакальный индекс КШ—коронарное шунтирование ЛЖ—левый
желудочек МНО—международное нормализованное отношение МРТ—магнитно …
желудочек МНО—международное нормализованное отношение МРТ—магнитно …
Diagnosis, prognosis, and therapy of transthyretin amyloidosis
MA Gertz, MD Benson, PJ Dyck, M Grogan… - Journal of the American …, 2015 - jacc.org
Transthyretin amyloidosis is a fatal disorder that is characterized primarily by progressive
neuropathy and cardiomyopathy. It occurs in both a mutant form (with autosomal dominant …
neuropathy and cardiomyopathy. It occurs in both a mutant form (with autosomal dominant …
Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis
A Castano, M Haq, DL Narotsky, J Goldsmith… - JAMA …, 2016 - jamanetwork.com
Importance Transthyretin cardiac amyloidosis (also known as ATTR cardiac amyloidosis) is
an increasingly recognized cause of heart failure with preserved ejection fraction. In single …
an increasingly recognized cause of heart failure with preserved ejection fraction. In single …
Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week
M Hanna, FL Ruberg, MS Maurer, A Dispenzieri… - Journal of the American …, 2020 - jacc.org
Technetium-labeled cardiac scintigraphy (ie, Tc-PYP scan) has been repurposed for the
diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM). Validated in cohorts of …
diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM). Validated in cohorts of …
Transthyretin cardiac amyloidosis: an update on diagnosis and treatment
H Yamamoto, T Yokochi - ESC heart failure, 2019 - Wiley Online Library
Transthyretin cardiac amyloidosis (ATTR‐CA) demonstrates progressive, potentially fatal,
and infiltrative cardiomyopathy caused by extracellular deposition of transthyretin‐derived …
and infiltrative cardiomyopathy caused by extracellular deposition of transthyretin‐derived …
Occult transthyretin cardiac amyloid in severe calcific aortic stenosis: prevalence and prognosis in patients undergoing surgical aortic valve replacement
TA Treibel, M Fontana, JA Gilbertson… - Circulation …, 2016 - Am Heart Assoc
Background—Calcific aortic stenosis (cAS) affects 3% of individuals aged> 75 years,
leading to heart failure and death unless the valve is replaced. Wild-type transthyretin …
leading to heart failure and death unless the valve is replaced. Wild-type transthyretin …
Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK)
A Yilmaz, J Bauersachs, F Bengel, R Büchel… - Clinical Research in …, 2021 - Springer
Systemic forms of amyloidosis affecting the heart are mostly light-chain (AL) and
transthyretin (ATTR) amyloidoses. The latter is caused by deposition of misfolded …
transthyretin (ATTR) amyloidoses. The latter is caused by deposition of misfolded …